A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy (Q26820819)

R. I. Glass

2

1 reference

B. Jiang

3

1 reference

M. Santosham

4

1 reference

B. Lopman

5

1 reference

language of work or name

1 reference

15 July 2013

1 reference

Journal of Infectious Diseases

published in

1 reference

volume

208

1 reference

issue

2

1 reference

page(s)

284-94

1 reference

Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Efficacy of the oral pentavalent rotavirus vaccine in Mali

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Performance of rotavirus vaccines in developed and developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Primer on certain elements of medical decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Immunogenicity, reactogenicity and safety of a human rotavirus vaccine (RIX4414) in Korean infants: a randomized, double-blind, placebo-controlled, phase IV study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Immunogenicity of the pentavalent rotavirus vaccine in African infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Oral rotavirus vaccines: how well will they work where they are needed most?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Immunity and correlates of protection for rotavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

The role of serum antibodies in the protection against rotavirus disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Rotavirus vaccines: how they work or don't work

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Rotavirus: realising the potential of a promising vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Experience of pentavalent human-bovine reassortant rotavirus vaccine among healthy infants in Taiwan

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Serum antibody as a marker of protection against natural rotavirus infection and disease

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Immunogenicity of a live-attenuated human rotavirus RIX4414 vaccine with or without buffering agent

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021

Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine in Kolkata India

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT166

7 January 2021